In the article entitled “Hi-Fidelity Fill/Finish for Biologics”, Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, emphasizes the sensitivity of lentiviral vectors to external factors, and talks about the convenience of freezing them as soon as the production process is finished, something that VIVEbiotech does.
You can read the full article here: https://www.biopharminternational.com/view/hi-fidelity-fill-finish-for-biologics